α-Tocopheryl succinate inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors

被引:31
作者
Stapelberg, M
Tomasetti, M
Alleva, R
Gellert, N
Procopio, A
Neuzil, J [1 ]
机构
[1] Griffith Univ, Sch Hlth Sci, Southport, Qld, Australia
[2] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, Ancona, Italy
[3] IRCCS, Ist Ortoped Rizzoli, Dept Anesthesiol, Bologna, Italy
[4] Acad Sci Czech Republ, Inst Mol Genet, Lab Apoptosis & Cellular Signalling, Prague, Czech Republic
关键词
vitamin E succinate; proliferation; apoptosis; FGF receptor signalling;
D O I
10.1016/j.bbrc.2004.04.072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
alpha-Tocopheryl succinate (alpha-TOS), a redox-silent analogue of vitamin E, inhibits malignant mesotheliomas (MM) in a pre-clinical model. Here we investigated the underlying mechanism. Exposure of MM cells to alpha-TOS triggered apoptosis at higher and inhibited proliferation at lower concentrations, while this effect was not observed in non-malignant mesothelial cells. Sub-apoptotic doses of alpha-TOS caused down-regulation of fibroblast growth factor receptor-1 (FGFR1) selectively in MM cells, while the effect on FGFR2 was only marginal. FGF1 and FGF2 enhanced MM cell proliferation that was suppressed by alpha-TOS. Over-expression of E2F1, a transcriptional factor of FGFR1, but not its dominant-negative counterpart, partially blocked the inhibitory activity of alpha-TOS on MM cell proliferation. Our data suggest a novel mechanism by which a clinically intriguing agent selectively suppresses proliferation of cancer cells, as shown here for the untreatable mesotheliomas. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:636 / 641
页数:6
相关论文
共 40 条
[1]
Predictive and prognostic factors in malignant pleural mesotheliorna [J].
Baas, P .
CURRENT OPINION IN ONCOLOGY, 2003, 15 (02) :127-130
[2]
EXPRESSION OF GROWTH-FACTOR AND GROWTH-FACTOR RECEPTOR RNA IN RAT PLEURAL MESOTHELIAL CELLS IN CULTURE [J].
BERMUDEZ, E ;
EVERITT, J ;
WALKER, C .
EXPERIMENTAL CELL RESEARCH, 1990, 190 (01) :91-98
[3]
Recent advances in mesothelioma [J].
Dark, G .
CLINICAL MEDICINE, 2003, 3 (04) :314-317
[4]
DiMario JX, 2002, INT J MOL MED, V10, P65
[5]
Feng SJ, 1997, CANCER RES, V57, P5369
[6]
Freeman KW, 2003, CANCER RES, V63, P6237
[7]
Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas [J].
Gorgoulis, VG ;
Zacharatos, P ;
Mariatos, G ;
Kotsinas, A ;
Bouda, M ;
Kletsas, D ;
Asimacopoulos, PJ ;
Agnantis, N ;
Kittas, C ;
Papavassiliou, AG .
JOURNAL OF PATHOLOGY, 2002, 198 (02) :142-156
[8]
Kim SJ, 1998, J CELL SCI, V111, P435
[9]
Potentiation of anti-cancer effect by intravenous administration of vesiculated α-tocopheryl hemisuccinate on mouse melanoma in vivo [J].
Kogure, K ;
Manabe, S ;
Hama, S ;
Tokumura, A ;
Fukuzawa, K .
CANCER LETTERS, 2003, 192 (01) :19-24
[10]
Kumar-Singh S, 1999, J PATHOL, V189, P72, DOI 10.1002/(SICI)1096-9896(199909)189:1<72::AID-PATH401>3.0.CO